Showing results (191-200 of 352) with videos related to
Sort By:
Pageof 36
Clinical Pharmacology and Therapeutics|April 1, 1978
Theophylline disposition in obesityP Gal, W J Jusko, A M Yurchak, et al.Antimicrobial Agents and Chemotherapy|November 1, 1981
Mezlocillin disposition in chronic hemodialysis patientsD M Janicke, A Mangione, R W Schultz, et al.Journal of Clinical Pharmacology|April 17, 2001
Clinical pharmacokinetics and pharmacodynamics of a new squalene synthase inhibitor, BMS-188494, in healthy volunteersA Sharma, P H Slugg, J L Hammett, et al.Antimicrobial Agents and Chemotherapy|March 1, 1982
Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairmentA Mangione, F D Boudinot, R M Schultz, et al.Pharmaceutical Research|December 2, 1998
Estimation of oral bioavailability of a long half-life drug in healthy subjectsA Sharma, P H Slugg, J L Hammett, et al.Clinical Pharmacology and Therapeutics|March 30, 1999
Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteersA Chakraborty, R A Blum, D L Cutler, et al.Journal of Clinical Pharmacology|March 28, 2001
Pharmacodynamic modeling of lansoprazole using an indirect irreversible response modelT A Puchalski, W Krzyzanski, R A Blum, et al.British Journal of Clinical Pharmacology|September 1, 1983
Effects of tobacco smoking and oral contraceptive use on theophylline dispositionM J Gardner, K M Tornatore, W J Jusko, et al.Clinical Pharmacology and Therapeutics|May 11, 1991
Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisoloneS K Yamashita, E A Ludwig, E Middleton, et al.Biochemical Pharmacology|February 1, 1982
Prednisolone binding to albumin and transcortin in the presence of cortisolM L Rocci, R D'Ambrosio, N F Johnson, et al.Pageof 36